滴氧测序增强了在胃肠道流体瘤中KIT突变的检测,最初通过下一代测序热点面板进行评估
Lisa Robinson1, Sharleen Rapp1, Weiwei Zhang1
1Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska.
The Journal of molecular diagnostics : JMD
|December 20, 2025
概括
下一代测序 (NGS) 可能会错过胃肠道 stromal 瘤 (GIST) 中的关键 KIT 突变. 脱氧测序对于识别这些临床可行的变体至关重要,特别是更大的删除或重复.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子诊断学 分子诊断学
背景情况:
- 胃肠道 stromal 瘤 (GIST) 主要是由 KIT 或 PDGFRA 基因的突变驱动的.
- 精确的突变检测对于指导最佳GIST治疗至关重要.
- 下一代测序 (NGS) 面板提供同时基因评估,但可能会在短读格式中与大变异作斗争.
研究的目的:
- 评估基于片的半导体NGS在检测GIST中的KIT和PDGFRA突变中的有效性.
- 评估NGS错过的临床可操作突变率.
- 确定替代测序方法的必要性,以进行全面的GIST突变分析.
主要方法:
- 在9年内对55名GIST患者样本进行了分析,使用各种基于AMPLIQON的NGS面板 (Ion AmpliSeq癌症热点面板v2,GIST面板,Oncomine精度测试).
- 脱氧测序用于NGS检测阴性病例,以检测KIT和PDGFRA突变.
- 在NGS和二氧化测序之间比较突变检测率.
主要成果:
- 在85%的病例中,NGS发现了KIT或PDGFRA突变.
- 另外9%的标本 (5分之55) 仅在二氧化测序后才为致病性KIT突变呈阳性.
- 总共有12%的所有已识别的KIT突变,特别是12-39个核酸删除或重复变异,需要进行二氧化测序来检测.
结论:
- 短读,基于片的NGS测定可能无法检测到GIST中显著比例的临床相关的KIT突变.
- 替代测试方式,如二氧化测序,建议用于由NGS负的GIST病例,以确保全面的突变识别.
- 需要考虑NGS的局限性来检测更大的插入/删除变体.
相关概念视频
Next-generation Sequencing
97.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.6K
Sanger Sequencing
772.8K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
772.8K


